Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) represent a distinct hypervascularized tumor entity, often diagnosed at metastatic stage. Therapeutic efficacy of anti-angiogenic multi-kinase inhibitors is frequently limited by primary or acquired resistance in vivo. This study aimed to characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Egidi, Maren Juliane, Krug, Sebastian, Haybaeck, Johannes, Michl, Patrick, Griesmann, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575939/
https://www.ncbi.nlm.nih.gov/pubmed/37620408
http://dx.doi.org/10.1038/s41416-023-02389-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575939/
https://www.ncbi.nlm.nih.gov/pubmed/37620408
http://dx.doi.org/10.1038/s41416-023-02389-6

Ejemplares similares